Awen M Gallimore (Awen Gallimore)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Immunology

Cancer immunology, immunotherapy : CII

Cancer immunology research

The Journal of biological chemistry

Cardiff University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cardiff University Aug 01 2013

United Kingdom

Professor :: Infection and Immunity

Cardiff University Aug 01 2009 - Jul 31 2013

United Kingdom

Reader :: Infection and Immunity

Cardiff University Jan 04 2003 - Jul 30 2009

United Kingdom

Senior Research Fellow :: Infection and Immunity

University of Oxford Dec 01 1999 - Mar 30 2003

United Kingdom

Research Fellow :: Nuffield Department of Medicine

Oxford University Dec 01 1998 - Nov 01 1999

United Kingdom

Post-doc :: Nuffield Department of Medicine

Universität Zurich May 01 1996 - Nov 01 1998

Switzerland

Post-doc :: Experimental Immunology

Publications

Stefan Milutinovic, Awen M Gallimore
The link between T cell activation and development of functionally useful tumour-associated high endothelial venules. Discovery immunology 2 (1) (2023)
Awen M Gallimore
Tumor-Associated High Endothelial Venules: Inroads Enabling Immune Control of Cancer Progression. Cancer immunology research 10 (4) (2022)
Martin J Scurr, Wioleta Milena Zelek, George Lippiatt, Michelle Somerville, Stephanie E A Burnell, Lorenzo Capitani, Kate Davies, Helen Lawton, Thomas Tozer, Tara Rees, Kerry Roberts, Mererid Evans, Amanda Jackson, Charlotte Young, Lucy C Fairclough, Paddy Tighe, Mark Wills, Andrew D Westwell, B Paul Morgan, Awen M Gallimore, Andrew Godkin
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers. Immunology (2021)
Alicia Teijeira Crespo, Stephanie Burnell, Lorenzo Capitani, Rebecca Bayliss, Elise Moses, Georgina H Mason, James A Davies, Andrew J Godkin, Awen M Gallimore, Alan L Parker
Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity. Immunology 163 (4) (2021)
Stephanie E A Burnell, Lorenzo Capitani, Bruce J MacLachlan, Georgina H Mason, Awen M Gallimore, Andrew Godkin
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity. Immunotherapy advances 2 (1) (2021)
Ana Pires, Alexander Greenshields-Watson, Emma Jones, Kathryn Smart, Sarah Nicol Lauder, Michelle Somerville, Stefan Milutinovic, Howard Kendrick, James P Hindley, Rhiannon French, Matthew John Smalley, William J Watkins, Robert Andrews, Andrew Godkin, Awen M Gallimore
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection. Cancer immunology research 8 (12) (2020)
Stephanie J Hanna, Amy S Codd, Ester Gea-Mallorqui, D Oliver Scourfield, Felix Clemens Richter, Kristin Ladell, Mariana Borsa, Ewoud B Compeer, Owen R Moon, Sarah A E Galloway, Matthias Frank, Lorenzo Capitani, Freya R Shepherd, Joseph D Wilson, Lion F K Uhl, null null, Awen M Gallimore, Anita Milicic
T cell phenotypes in COVID-19 - a living review. Oxford open immunology 2 (1) (2020)
Ellyn Hughes, Sarah N Lauder, Kathryn Smart, Anja Bloom, Jake Scott, Emma Jones, Michelle Somerville, Molly Browne, Andrew Blainey, Andrew Godkin, Ann Ager, Awen M Gallimore
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion. Cancer immunology, immunotherapy : CII 69 (10) (2020)
Bruce J MacLachlan, Garry Dolton, Athanasios Papakyriakou, Alexander Greenshields-Watson, Georgina H Mason, Andrea Schauenburg, Matthieu Besneux, Barbara Szomolay, Tim Elliott, Andrew K Sewell, Awen M Gallimore, Pierre J Rizkallah, David K Cole, Andrew Godkin
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope. The Journal of biological chemistry 294 (52) (2019)
Ellyn Hughes, Martin Scurr, Emma Campbell, Emma Jones, Andrew Godkin, Awen M Gallimore
T-cell modulation by cyclophosphamide for tumour therapy. Immunology 154 (1) (2018)
Matthieu Besneux, Alexander Greenshields-Watson, Martin J Scurr, Bruce J MacLachlan, Adam Christian, Michael M Davies, Rachel Hargest, Simon Phillips, Andrew Godkin, Awen M Gallimore
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design. Cancer immunology, immunotherapy : CII 68 (2) (2018)

Awen M Gallimore.css-eqlu8i{font-size:small;padding-left:4px;} (Awen Gallimore)

Publication Activity (10 Years)

Top Topics

Top Venues

Awen M Gallimore (Awen Gallimore)